Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands.
Age Ageing. 2018 Jul 1;47(4):545-550. doi: 10.1093/ageing/afy072.
the appropriateness of lowering systolic blood pressure remains controversial in the oldest-old. We tested whether systolic blood pressure is associated with all-cause mortality and change in cognitive function for patients prescribed antihypertensive treatment and those without treatment.
we studied participants in the population-based Leiden 85-plus cohort study. Baseline systolic blood pressure and use of antihypertensive treatment were predictors; all-cause mortality and change in cognitive function measured using the Mini-Mental State Examination were the outcomes. Grip strength was measured as a proxy for physical frailty. We used Cox proportional hazards and mixed-effects linear regression models to analyse the relationship between systolic blood pressure and both time to death and change in cognitive function. In sensitivity analyses, we excluded deaths within 1 year and restricted analyses to participants without a history of cardiovascular disease.
of 570 participants, 249 (44%) were prescribed antihypertensive therapy. All-cause mortality was higher in participants with lower blood pressure prescribed antihypertensive treatment (HR 1.29 per 10 mmHg lower systolic blood pressure, 95% CI 1.15-1.46, P < 0.001). Participants taking antihypertensives showed an association between accelerated cognitive decline and lower blood pressure (annual mean change -0.35 points per 10 mmHg lower systolic blood pressure, 95% CI -0.60, -0.11, P = 0.004); decline in cognition was more rapid in those with lower hand grip strength. In participants not prescribed antihypertensive treatment, no significant associations were seen between blood pressure and either mortality or cognitive decline.
lower systolic blood pressure in the oldest-old taking antihypertensives was associated with higher mortality and faster decline in cognitive function.
在最年长的老年人中,降低收缩压的适宜性仍然存在争议。我们测试了收缩压是否与接受抗高血压治疗和未接受治疗的患者的全因死亡率和认知功能变化有关。
我们研究了基于人群的莱顿 85 岁以上队列研究的参与者。收缩压和抗高血压治疗的使用是预测因素;全因死亡率和使用 Mini-Mental State Examination 测量的认知功能变化是结果。握力作为身体虚弱的替代指标进行测量。我们使用 Cox 比例风险和混合效应线性回归模型来分析收缩压与死亡时间和认知功能变化之间的关系。在敏感性分析中,我们排除了 1 年内死亡的患者,并将分析限制在没有心血管疾病史的参与者中。
在 570 名参与者中,有 249 名(44%)接受了抗高血压治疗。接受抗高血压治疗的血压较低的患者全因死亡率较高(每降低 10mmHg 收缩压的 HR 为 1.29,95%CI 为 1.15-1.46,P<0.001)。服用抗高血压药物的患者与血压较低之间存在认知能力下降加速的关联(每降低 10mmHg 收缩压的年平均变化为-0.35 分,95%CI-0.60,-0.11,P=0.004);握力较低的患者认知能力下降更快。在未接受抗高血压治疗的患者中,血压与死亡率或认知功能下降之间没有显著关联。
服用抗高血压药物的最年长老年人的收缩压较低与死亡率较高和认知功能下降较快有关。